EUVIMEDEUVIMED entdecken
Leserbrief

Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial

Isabel C Balachandran, Matthew W Segar, Nikolaos A Diakos, Joseph G Rogers

Journal of Cardiac Failure · 2023

DOI: 10.1016/j.cardfail.2023.06.012 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Cardiac Failure, 2023. Verfasst von Isabel C Balachandran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Texas Heart Institute, Houston, TX. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHeart-Assist DevicesHumansTime FactorsTreatment OutcomeClinical Trials as Topic

Autor:innen und Institutionen

  • Department of Cardiology, The Texas Heart Institute, Houston, TX.
  • Department of Cardiology, The Texas Heart Institute, Houston, TX.. Electronic address: Jrogers@texasheart.org.

Zitieren

APA

Balachandran, I. C., Segar, M. W., Diakos, N. A., & Rogers, J. G. (2023). Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2023.06.012

Vancouver

Balachandran IC, Segar MW, Diakos NA, Rogers JG. Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. Journal of Cardiac Failure. 2023. doi:10.1016/j.cardfail.2023.06.012

BibTeX
@article{Balachandran2023,
  author = {Balachandran, Isabel C and Segar, Matthew W and Diakos, Nikolaos A and Rogers, Joseph G},
  title = {Conditional Survival After HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial},
  journal = {Journal of Cardiac Failure},
  year = {2023},
  doi = {10.1016/j.cardfail.2023.06.012}
}
Kostenlos starten →